10x Genomics, Inc. TXG Europe, Middle East and Africa — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s europe, middle east and africa — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s europe, middle east and africa — revenue?
- 10x Genomics, Inc. (TXG) reported europe, middle east and africa — revenue of $36.85M in Q1 2026.
- How has 10x Genomics, Inc.'s europe, middle east and africa — revenue changed year-over-year?
- 10x Genomics, Inc.'s europe, middle east and africa — revenue increased by 15.5% year-over-year, from $31.9M to $36.85M.
- What is the long-term trend for 10x Genomics, Inc.'s europe, middle east and africa — revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s europe, middle east and africa — revenue has grown at a 10.5% compound annual growth rate (CAGR), from $108.49M to $161.72M.
- What does europe, middle east and africa — revenue mean?
- This metric represents the total net sales generated from customers located within the Europe, Middle East, and Africa (EMEA) geographic region. It reflects the company's market penetration and demand for its life science instruments, consumables, and software solutions in these specific international markets. Monitoring this figure helps investors assess the company's global expansion strategy and the relative performance of its international sales operations.